1185 related articles for article (PubMed ID: 29174216)
1. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
2. A randomized crossover study to assess the pharmacokinetics of a novel amphetamine extended-release orally disintegrating tablet in healthy adults.
Stark JG; Engelking D; McMahen R; Sikes C
Postgrad Med; 2016 Sep; 128(7):648-55. PubMed ID: 27488574
[TBL] [Abstract][Full Text] [Related]
3. A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults.
Sikes C; Stark JG; McMahen R; Engelking D
J Atten Disord; 2020 Feb; 24(3):414-419. PubMed ID: 29192549
[No Abstract] [Full Text] [Related]
4. A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults.
Newcorn JH; Stark JG; Adcock S; McMahen R; Sikes C
Clin Ther; 2017 Aug; 39(8):1695-1705. PubMed ID: 28760535
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release.
Ermer JC; Shojaei A; Pennick M; Anderson CS; Silverberg A; Youcha SH
Curr Med Res Opin; 2007 May; 23(5):1067-75. PubMed ID: 17519073
[TBL] [Abstract][Full Text] [Related]
6. Fed and Fasted Administration of a Novel Extended-Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD.
Weisler RH; Stark JG; Sikes C
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):160-167. PubMed ID: 28544344
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine.
Kinzler ER; Pantaleon C; Iverson M; Aigner S
Adv Ther; 2019 Sep; 36(9):2394-2401. PubMed ID: 31278694
[TBL] [Abstract][Full Text] [Related]
8. An Open-Label, Multicenter, Single-Dose Pharmacokinetic Study of a Novel Amphetamine Extended-Release Orally Disintegrating Tablet in Preschool-Aged Children.
Marraffino A; Sikes CR; Laage T; Volosov A; Hart A; Engelking D
J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):15-20. PubMed ID: 31295008
[No Abstract] [Full Text] [Related]
9. Effects of Food Intake on the Relative Bioavailability of Amifampridine Phosphate Salt in Healthy Adults.
Haroldsen PE; Musson DG; Hanson B; Quartel A; O'Neill CA
Clin Ther; 2015 Jul; 37(7):1555-63. PubMed ID: 26101174
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension.
Pardo A; Kando JC; King TR; Rafla E; Herman BK
CNS Spectr; 2020 Dec; 25(6):774-781. PubMed ID: 31964449
[TBL] [Abstract][Full Text] [Related]
12. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
13. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
14. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration.
Tulloch SJ; Zhang Y; McLean A; Wolf KN
Pharmacotherapy; 2002 Nov; 22(11):1405-15. PubMed ID: 12432966
[TBL] [Abstract][Full Text] [Related]
15. Single-Dose Pharmacokinetics of Amphetamine Extended-Release Oral Suspension in Healthy Adults.
Herman BK; Bouhajib M; King TR; Kando JC; Pardo A
J Atten Disord; 2021 Apr; 25(6):803-808. PubMed ID: 31027435
[No Abstract] [Full Text] [Related]
16. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
Zomorodi K; Kankam M; Lu Y
Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
[TBL] [Abstract][Full Text] [Related]
17. Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults.
Clausen SB; Read SC; Tulloch SJ
CNS Spectr; 2005 Dec; 10(12 Suppl 20):6-15. PubMed ID: 16344836
[TBL] [Abstract][Full Text] [Related]
18. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
Yang L; Zhang L; Luo Z
Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
[TBL] [Abstract][Full Text] [Related]
19. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
Sikes CR; McMahen RL; Stark JG; Engelking D
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):29-35. PubMed ID: 28933918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
